EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase – Should You Buy?

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) saw an uptick in trading volume on Friday . Approximately 286,351 shares were traded during trading, an increase of 133% from the previous session’s volume of 123,027 shares.The stock last traded at $95.03 and had previously closed at $94.60.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Zacks Research lowered shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of EssilorLuxottica in a research report on Tuesday, May 12th. They issued a “hold” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, EssilorLuxottica presently has a consensus rating of “Moderate Buy”.

Get Our Latest Analysis on ESLOY

EssilorLuxottica Stock Performance

The stock has a 50-day moving average price of $98.41 and a two-hundred day moving average price of $117.32. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Further Reading

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.